In the last issue, we took a look at the nucleoside analogue 'backbone' of anti-HIV treatment, but a strong backbone is only part of the story -- it needs something to hold up. This Backgrounder looks at the protease inhibitor class of drugs.
From the April 2006 issue of Positive Living
In the last issue, we took a look at the nucleoside analogue 'backbone' of anti-HIV treatment, but a strong backbone is only part of the story -- it needs something to hold up. This Backgrounder looks at the protease inhibitor class of drugs.
From the July 2005 issue of Positive Living
From the August 2003 issue of Positive Living